ABM Therapeutics

ABM Therapeutics (ABM) is a clinical-stage biopharmaceutical company founded in 2015, operating from San Diego, California and Zhangjiang, Pudong, Shanghai. It discovers and develops small-molecule targeted therapies for primary brain cancers including glioblastoma multiforme (GBM) and for brain metastases arising from melanoma, lung cancer and breast cancer. Its lead program, ABM-1310, is a brain-penetrant, selective BRAF V600 inhibitor that received US IND clearance in November 2019 and is in Phase 1 clinical study. ABM publishes no developer program, public API, SDK or machine-readable specification; its only public surface is a corporate, investor and clinical-news website. The company was surfaced through the API Evangelist harvest backlog from a secondary-market listing under the ticker-style slug "abmtx".

ABM Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Life Sciences, and Oncology.

🌐 Visit website 📡 Source on GitHub
4.1/100 minimal Agent 0/100 human only Full breakdown ↓
scored 2026-09-06 · rubric v0.19.0
0 APIs
CompanyBiotechnologyPharmaceuticalsLife SciencesOncologyDrug DiscoveryClinical TrialsHealthcare

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-09-06 · rubric v0.19.0
Composite quality — 4.1/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.0 / 17
Access Clarity 0.0 / 17
Operational Transparency 0.0 / 11
Contract Governance 0.0 / 10
Discoverability 4.9 / 9
Regulatory Posture 1.1 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
Documented Reversibility 0 / 6
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Delegated User Identity 0 / 6
Protected Resource Metadata 0 / 5
Registration Without a Human 0 / 6
Agentic Commerce Well-Known Document 0 / 5
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/abmtx: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Abmtx Domain Security

no transport/DNS hardening detected

SECURITY

Resources

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt
LLMsTxt

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Contact
Contact

Company 5

The organization behind the API

Website
Website
 About
About
 Newsroom
Newsroom
 InvestorRelations
InvestorRelations
 LinkedIn
LinkedIn

Other 1

Properties that don't map to a standard resource type

x-secondary-market-listing
x-secondary-market-listing

Source (apis.yml)

apis.yml Raw ↑ 
aid: abmtx
name: ABM Therapeutics
description: ABM Therapeutics (ABM) is a clinical-stage biopharmaceutical company founded in 2015, operating from San Diego,
  California and Zhangjiang, Pudong, Shanghai. It discovers and develops small-molecule targeted therapies for primary brain
  cancers including glioblastoma multiforme (GBM) and for brain metastases arising from melanoma, lung cancer and breast cancer.
  Its lead program, ABM-1310, is a brain-penetrant, selective BRAF V600 inhibitor that received US IND clearance in November
  2019 and is in Phase 1 clinical study. ABM publishes no developer program, public API, SDK or machine-readable specification;
  its only public surface is a corporate, investor and clinical-news website. The company was surfaced through the API Evangelist
  harvest backlog from a secondary-market listing under the ticker-style slug "abmtx".
image: http://www.abmtx.com/themes/basic/skin/images/icon_logo.jpg
url: https://raw.githubusercontent.com/api-evangelist/abmtx/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enriched
specificationVersion: '0.20'
created: '2026-09-06'
modified: '2026-09-06'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Life Sciences
- Oncology
- Drug Discovery
- Clinical Trials
- Healthcare
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/abmtx-domain-security.yml
- type: LLMsTxt
  url: llms/abmtx-llms.txt
- type: Website
  url: http://www.abmtx.com/
- type: About
  url: http://www.abmtx.com/site/company
- type: Contact
  url: http://www.abmtx.com/site/contactus
- type: Newsroom
  url: http://www.abmtx.com/site/newscenter
- type: InvestorRelations
  url: http://www.abmtx.com/site/Investors
- type: LinkedIn
  url: https://www.linkedin.com/company/abm-therapeutics
- type: x-secondary-market-listing
  url: https://www.hiive.com/securities/abmtx-stock
x-enrichment:
  date: '2026-09-06'
  status: minimal
  artifacts_added: 3
  pass: local-v3
x-coverage:
  state: none
  reason: not-a-software-company
  detail: ABM Therapeutics is a clinical-stage biopharmaceutical company developing small-molecule brain-cancer drugs (lead
    program ABM-1310); its entire public surface is a PHP-CMS corporate and investor brochure at http://www.abmtx.com/ that
    serves no developer section, and no api./developer./developers./docs. subdomain for abmtx.com resolves at all.
  evidence:
  - url: http://www.abmtx.com/
    status: 200
  - url: http://www.abmtx.com/openapi.json
    status: 404
  - url: http://www.abmtx.com/llms.txt
    status: 404
  - url: http://www.abmtx.com/.well-known/api-catalog
    status: 404
  - url: http://abmtx.com/.well-known/agent-card.json
    status: 404
  checked: '2026-09-06'

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this
  • find_providersBrowse and filter every provider in the catalog.
  • get_provider_artifactsEvery artifact this provider publishes, grouped by type.
  • get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
  • get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
  • get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
  • get_provider_ratingPRO — composite, band, trend and facet scores.
  • apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
  • resolveTurn a domain, URL or GitHub org into the provider it belongs to.
  • find_cohortsEvery scored population of providers in the catalog.
All 92 tools →

Call it yourself

curl for this page
This provider 
curl "https://apis.io/api/v1/providers/abmtx"
All providers 
curl "https://apis.io/api/v1/providers?limit=25"
Every operation they expose 
curl "https://apis.io/api/v1/providers/abmtx/operations?limit=25"
How their score was established 
curl "https://apis.io/api/v1/providers/abmtx/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no email required.

GitHub Google LinkedIn

A second provider on the same verified email joins the account you already have.